Skip to main content

Advertisement

Log in

Cardiotoxicity after low-dose chloroquine antimalarial therapy

  • Case Report
  • Published:
Heart and Vessels Aims and scope Submit manuscript

Abstract

Previous reports on antimalarial toxicity have only been related to long-term continuous treatments for nonmalarial indications, which require prolonged use of large doses, up to 1000 g or more every year. We describe a patient with recurrent malaria, prophylactically treated with low-dose chloroquine, who developed heart failure due to biventricular cardiac dysfunction. The right ventricle endomyocardial biopsy was suggestive of chloroquine toxicity. The heart failure improved after drug withdrawal. As a consequence, the potential for reversibility and the severity in undiagnosed cases of these toxic cardiomyopathies emphasize the importance of recognizing early signs of toxicity in order to withdraw antimalarials before the occurrence of life-threatening cardiac toxicity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ochsendorf FR, Runne U (1991) Chloroquine and hydroxychloroquine: side effect profile of important therapeutic drugs. Hautarzt 42:140–146

    PubMed  CAS  Google Scholar 

  2. Whisnant JP, Espinosa RE, Kierland RR, Lambert EH (1963) Chloroquine neuromyopathy. Proc Staff Meet Mayo Clin 38:501–513

    PubMed  CAS  Google Scholar 

  3. Magnussen I, de Fine Olivarius B (1977) Cardiomyopathy after chloroquine treatment. Acta Med Scand 202:429–431

    PubMed  CAS  Google Scholar 

  4. Hughes JT, Esiri M, Oxbury JM, Whitty CW (1971) Chloroquine myopathy. Q J Med 40:85–93

    PubMed  CAS  Google Scholar 

  5. Oli JM, Ihenacho HN, Talwar RS (1980) Chronic chloroquine toxicity and heart block: a report of two cases. East Afr Med J 57:505–507

    PubMed  CAS  Google Scholar 

  6. Piette JC, Guillevin L, Chapelon C, Wechsler B, Bletry O, Godeau P (1987) Chloroquine cardiotoxicity. N Engl J Med 317:710–711

    PubMed  CAS  Google Scholar 

  7. McAllister HA Jr, Ferrans VJ, Hall RJ, Strickman NE, Bossart MI (1987) Chloroquine-induced cardiomyopathy. Arch Pathol Lab Med 111:953–956

    PubMed  Google Scholar 

  8. Ratliff NB, Estes ML, Myles JL, Shirey EK, McMahon JT (1987) Diagnosis of chloroquine cardiomyopathy by endomyocardial biopsy. N Engl J Med 316:191–193

    PubMed  CAS  Google Scholar 

  9. Estes ML, Ewing-Wilson D, Chou SM, Mitsumoto H, Hanson M, Shirey E, Ratliff NB (1987) Chloroquine neuromyotoxicity. Clinical and pathological perspective. Am J Med 82:447–455

    Article  PubMed  CAS  Google Scholar 

  10. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises (1988) Case 38-1988. A 58-year-old woman with fever, sweats, congestive heart failure, and lymphadenopathy after treatment for a diagnosis of systemic lupus erythematosus. N Engl J Med 319:768–781

    Article  Google Scholar 

  11. Ogola ES, Muita AK, Adala H (1992) Chloroquine related complete heart block with blindness: case report. East Afr Med J 69:50–52

    PubMed  CAS  Google Scholar 

  12. Fellahi JL, Dumazer P, Delayance S, Vernier I, Conte JJ (1993) Cardiomyopathy under treatment with hydroxychloroquine disclosed by complete auriculoventricular block. Rev Med Intern 14:275–276

    Article  CAS  Google Scholar 

  13. Verny C, De-Gennes C, Sebastien P, Le Thi Houng Du, Chapelon C, Piette JC, Chomette G, Godeau P (1992) Heart conduction disorders in long-term treatment with chloroquine. Two new cases. Presse Med 21:800–804

    CAS  Google Scholar 

  14. Iglesias Cubero G, Rodriguez Reguero JJ, Rojo Ortega JM (1993) Restrictive cardiomyopathy caused by chloroquine. Br Heart J 69:451–452

    Article  PubMed  CAS  Google Scholar 

  15. August C, Holzhausen HJ, Schmoldt A, Pompecki R, Schröder S (1995) Histological and ultrastructural findings in chloroquineinduced cardiomyopathy.. J Mol Med 73:73–77

    Article  PubMed  CAS  Google Scholar 

  16. Veinot JP, Mai KT, Zarychanski R (1998) Chloroquine related cardiac toxicity. J Rheumatol 25:1221–1225

    PubMed  CAS  Google Scholar 

  17. Baguet JP, Tremel F, Fabre M (1999) Chloroquine cardiomyopathy with conduction disorders. Heart 81:221–223

    PubMed  CAS  Google Scholar 

  18. Cervera A, Espinosa G, Font J, Ingelmo M (2001) Cardiac toxicity secondary to long-term treatment with chloroquine. Ann Rheum Dis 60:301.

    Article  PubMed  CAS  Google Scholar 

  19. Nord JE, Shah PK, Rinaldi RZ, Weisman MH (2004) Hydroxychloroquine cardiotoxicity in systemic lupus erythematosus: a report of 2 cases and review of the literature. Semin Arthritis Rheum 33:336–351

    Article  PubMed  CAS  Google Scholar 

  20. Charlier P, Cochand-Priollet B, Polivka M, Goldgran-Toledano D, Leenhardt A (2002) Chloroquine cardiomyopathy revealed by complete atrio-ventricular block. A case report. Arch Mal Coeur Vaiss 95:833–837

    PubMed  CAS  Google Scholar 

  21. Roos JM, Aubry MC, Edwards WD (2002) Chloroquine cardiotoxicity: clinicopathologic features in three patients and comparison with three patients with Fabry disease. Cardiovasc Pathol 11:277–283

    Article  PubMed  CAS  Google Scholar 

  22. Teixeira RA, Martinelli Filho M, Benvenuti LA, Costa R, Pedrosa AA, Nishioka SA (2002) Cardiac damage from chronic use of chloroquine: a case report and review of the literature. Arq Bras Cardiol 79:85–88

    Article  PubMed  Google Scholar 

  23. Freihage JH, Patel NC, Jacobs WR, Picken M, Fresco R, Malinowska K, Pisani BA, Mendez JC, Lichtenberg RC, Foy BK, Bakhos M, Mullen GM (2004) Heart transplantation in a patient with chloroquine-induced cardiomyopathy. J Heart Lung Transplant 23:252–255

    Article  PubMed  Google Scholar 

  24. Keating RJ, Bhatia S, Amin S, Williams A, Sinak LJ, Edwards WD (2005) Hydroxychloroquine-induced cardiotoxicity in a 39-yearold woman with systemic lupus erythematosus and systolic dysfunction. J Am Soc Echocardiogr 18:981

    PubMed  Google Scholar 

  25. Naqvi TZ, Luthringer D, Marchevsky A, Saouf R, Gul K, Buchbinder NA (2005) Chloroquine-induced cardiomyopathyechocardiographic features. J Am Soc Echocardiogr 18:383–387

    Article  PubMed  Google Scholar 

  26. Cotroneo J, Sleik KM, Rene Rodriguez E, Klein AL (2007) Hydroxychloroquine-induced restrictive cardiomyopathy. Eur J Echocardiogr 8:247–251

    Article  PubMed  Google Scholar 

  27. Costedoat-Chalumeau N, Hulot JS, Amoura Z, Delcourt A, Maisonobe T, Dorent R, Bonnet N, Sablé R, Lechat P, Wechsler B, Piette JC (2007) Cardiomyopathy related to antimalarial therapy with illustrative case report. Cardiology 107:73–80

    Article  PubMed  Google Scholar 

  28. Fragasso G, Palloshi A, Puccetti P, Silipigni C, Rossodivita A, Pala MG, Calori G, Alfieri O, Margonato A (2006) A randomized clinical trial of trimetazidine, a partial free fatty acid oxidation inhibitor, in patients with systolic dysfunction heart failure. J Am Coll Cardiol 48:992–998

    Article  PubMed  CAS  Google Scholar 

  29. Senju N, Ikeda S, Koga S, Miyahara Y, Tsukasaki K, Tomonaga M, Kohno S (2007) The echocardiographic Tei-index reflects early myocardial damage induced by anthracyclines in patients with hematological malignancies. Heart Vessels 22:393–397

    Article  PubMed  Google Scholar 

  30. Reuss-Borst M, Berner B, Wulf G, Muller GA (1999) Complete heart block as a rare complication of treatment with chloroquine. J Rheumatol 26:1394–1395

    PubMed  CAS  Google Scholar 

  31. Ladipo GO, Essien EE, Andy JJ (1983) Complete heart block in chronic chloroquine poisoning. Int J Cardiol 4:198–200

    Article  PubMed  CAS  Google Scholar 

  32. Sanmartí R, Gómez-Casanovas E, Solé M, Cañete J, Gratacós J, Carmona L, Gonzalez-Alvaro I, Muñoz-Gómez J (2004) Prevalence of silent amyloidosis in RA and its clinical significance. J Rheumatol 31:1013–1014

    PubMed  Google Scholar 

  33. Taniguchi R, Sato Y, Nishio Y, Kimura T, Kita T (2006). Measurements of baseline and follow-up concentrations of cardiac troponin-T and brain natriuretic peptide in patients with heart failure from various etiologies. Heart Vessels 21:344–349

    Article  PubMed  Google Scholar 

  34. Kato S, Morimoto S, Hiramitsu S, Uemura A, Ohtsuki M, Kato Y, Miyagishima K, Mori N, Hishida H (2007) Successful high-dose intravenous immunoglobulin therapy for a patient with fulminant myocarditis. Heart Vessels 22:48–51

    Article  PubMed  Google Scholar 

  35. Reffelmann T, Naami A, Spuentrup E, Kühl PH (2006) Contrastenhanced magnetic resonance imaging of a patient with chloroquine-induced cardiomyopathy confirmed by endomyocardial biopsy. Circulation 114:e357–e358

    Article  PubMed  Google Scholar 

  36. Pieroni M, Bellocci F, Crea F (2006) Letter regarding article, “Contrast-enhanced magnetic resonance imaging of a patient with chloroquine-induced cardiomyopathy confirmed by endomyocardial biopsy.” Circulation 114:e358.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gabriele Fragasso.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fragasso, G., Sanvito, F., Baratto, F. et al. Cardiotoxicity after low-dose chloroquine antimalarial therapy. Heart Vessels 24, 385–387 (2009). https://doi.org/10.1007/s00380-008-1144-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00380-008-1144-8

Key words

Navigation